The pathogenesis of craniosynostosis in the fetus

Yonsei Medical Journal

Volumn 42, Issue 6, 2001, Pages 646-659

  Warren, Stephen M ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cranial suture biology; Craniofacial disorders; Craniosynostosis; Dura mater; Osteoblast

Indexed keywords

GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHILDBIRTH; CHROMOSOME MUTATION; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DURA MATER; EMBRYO; FETUS; GENE MAPPING; GENE MUTATION; HUMAN; NEWBORN; NONHUMAN; PATHOGENESIS; PREMATURITY; RAT; REVIEW; SKULL DEVELOPMENT; SURGICAL APPROACH;

EID: 0035678334     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2001.42.6.646     Document Type: Review

References (114)

1. The pathogenesis of premature cranial synostosis in man
2. Molecular genetic advances in understanding craniosynostosis
3. Craniosynostoses: Phenotypic/molecular correlations
4. Craniosynostosis
5. Ultrasonic prenatal diagnosis of coronal suture synostosis
6. Second- trimester molecular prenatal diagnosis of sporadic Apert syndrome following suspicious ultrasound findings
7. Fibroblast growth factor receptor-2 mutations in craniosynostosis
8. Craniosynostosis and skeletal dysplasias: Fibroblast growth factor receptor defects
9. Transforming growth factor betas and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis
10. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome
11. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability
12. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis
13. Strike three for GL13
14. GL13 zinc- finger gene interrupted by translocations in Greig syndrome families
15. Point mutations in human GL13 cause Greig syndrome
16. Mutations of the TWIST gene in the Saethre-Chotzen syndrome
17. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome
18. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations
19. Intracranial pressure and intracranial volume in children with craniosynostosis
20. Modified prone position for cranial remodeling' procedures in children with craniofacial dysmorphism: A technical note
21. IQ and craniostenosis: Evolution in treated and untreated cases
22. Management of craniosynostoses
23. Ueber den Cretinismus, namentlich in Franken, und ueber pathologische Schaedelformen
24. Acrocephaly and scaphocephaly with symmetrically distributed malformations of the extremities
25. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion
26. Studies in cranial suture biology: Regional dura mater determines overlying suture biology
27. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro
28. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis
29. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production
30. Studies in cranial suture biology: In vitro cranial suture fusion
31. Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse
32. Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion
33. Studies in cranial suture biology: Part I. Increased immunoreactivity for transforming growth factor-beta (b1, b2, b3) during rat cranial suture fusion
34. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro
35. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF- beta 2 activity from fetal rat calvaria in vitro
36. Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures
37. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion
38. Biomolecular mechanisms of calvarial bone induction: Immature vs. mature dura mater
39. Immature vs. mature dura mater II: Differential expression of genes critical to calvarial re-ossification
40. Calvarial deformity regeneration following subtotal craniectomy for craniosynostosis: A case report and theoretical implications
41. Craniosynostosis: Genes and mechanisms
42. From head to toe: Conservation of molecular signals regulating limb and craniofacial morphogenesis
43. Fusion of the frontal suture in the rat
44. Regeneration of the calvarium in young normal and growth hormone-treated hypophysectomized rats
45. Calvarial and sutural redevelopment following craniectomy in the neonatal rabbit
46. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures
47. Inhibition and stimulation of sutural fusion in the rat calvaria
48. In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration
49. A molecular analysis of the isolated rat posterior frontal and sagittal sutures: Differences in gene expression
50. The effects of insulin like growth factor I on critical sized calvarial defects in Sprague Dawley rats
51. Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats
52. The effect of insulin growth factor-1 on calvarial sutures in a Sprague-Dawley rat
53. Increased IGF-1 and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion
54. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae
55. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone
56. Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunocytochemistry
57. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro
58. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations
59. Metalloproteinases and their inhibitors in matrix remodeling
60. Role of transforming growth factor-beta in bone remodeling
61. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures
62. The transforming growth factor-beta family
63. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures
64. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat
65. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation
66. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion
67. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta
68. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats
69. Functions of fibroblast growth factors and their receptors
70. Fibroblast growth factors in mammalian development
71. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain
72. Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats
73. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits
74. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria--an application of a new drug delivery system
75. The use of polymerase chain reaction generated nucleotide sequences as probes for hybridization
76. Regulation of fracture repair by growth factors
77. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin- diabetic rats
78. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells
79. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures
80. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
81. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation- related roles in the developing mouse skull vault
82. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome
83. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
84. In vivo modulation of FGF-biologic activity alters cranial suture fate
85. A confined variable region confers ligand specificity on fibroblast growth factor receptors: Implication for the origin of the immunoglobulin fold
86. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization
87. The human Fibroblast Growth Factor Receptor Genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain
88. Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction
89. Structural and functional diversity in the FGF receptor multigene family
90. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells
91. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras
92. Analysis of patients with craniosynostosis syndromes for a pro246Arg mutation of FGFR4
93. Identical mutations in FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
94. Crouzon syndrome: Mutations in two splice forms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome
95. Mutation detection in FGFR2 craniosynostosis syndromes
96. Genotype-phenotype correlation for nucleotide substitutions in the IglI-IgIII linker of FGFR2
97. Newly recognized autosomal dominant disorder with craniosynostosis
98. The molecular basis of Boston-type craniosynostosis: The Pro148→His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
99. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull
100. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation
101. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans
102. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development
103. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest
104. Developmental expression of two murine fibroblast growth factor receptors, flg and bek
105. Developmental localization of the splicing alternatives of Fibroblast Growth Factor Receptor-2 (FGFR2)
106. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos
107. Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification
108. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation
109. The mapping of a gene for craniosynostosis: Evidence for linkage of the Saethre-Chotzen syndrome to distal chromosome 7p
110. Mutations in the human TWIST gene
111. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell- cell interaction in the mouse embryo
112. FGF, BMP, and Shh mediated signaling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
113. The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos
114. Extra-toes: A new mutant gene causing multiple abnormalities in the mouse